MIM
ONC

Macroview Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Macroview Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$540 – 874
2023
Q3 		$540 Buy
+3
New +$594 ﹤0.01% 721

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Macroview Investment Management's ONC Position: Q4 2023 in Review

Macroview Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 3 shares — an estimated $540 sold.

Macroview Investment Management first reported a position in ONC in Q3 2023 and held it in 1 quarter. The position peaked at $540 in Q3 2023. 203 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Macroview Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Macroview Investment Management sold 3 BeOne Medicines Ltd shares in Q4 2023, an estimated $540.
  • Macroview Investment Management first reported a position in BeOne Medicines Ltd in Q3 2023 and held it in 1 quarter.
  • Macroview Investment Management's BeOne Medicines Ltd position peaked at $540 in Q3 2023.
  • 203 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Macroview Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.